The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Protagonist Therapeutics Inc shares valued at $30,986 were sold by Ali Asif on Apr 18 ’24. At $25.11 per share, Ali Asif sold 1,234 shares. The insider’s holdings dropped to 37,163 shares worth approximately $0.95 million following the completion of this transaction.
Also, PATEL DINESH V PH D sold 25,000 shares, netting a total of over 707,750 in proceeds. Following the sale of shares at $28.31 each, the insider now holds 549,590 shares.
Before that, PATEL DINESH V PH D had sold 30,000 shares from its account. In a trade valued at $948,600, the President and CEO traded Protagonist Therapeutics Inc shares for $31.62 each. Upon closing the transaction, the insider’s holdings decreased to 30,000 shares, worth approximately $14.68 million.
As published in their initiating research note from CapitalOne on October 30, 2023, Protagonist Therapeutics Inc [PTGX] has been an Overweight and the price target has been revised to $32. As of August 25, 2022, JMP Securities has initiated its “Mkt outperform” rating for PTGX. Earlier on February 11, 2022, BTIG Research initiated its rating. Their recommendation was “a Buy” for PTGX stock.
Analyzing PTGX Stock Performance
During the last five days, there has been a surge of approximately 3.57%. Over the course of the year, Protagonist Therapeutics Inc shares have jumped approximately 11.38%. Shares of the company reached a 52-week high of $33.34 on 03/01/24 and a 52-week low of $21.43 on 01/05/24. A 50-day SMA is recorded $28.13, while a 200-day SMA reached $21.90. Nevertheless, trading volume fell to 0.45 million shares from 0.7 million shares the previous day.
Support And Resistance Levels for Protagonist Therapeutics Inc (PTGX)
According to the 24-hour chart, there is a support level at 25.22, which, if violated, would cause prices to drop to 24.91. In the upper region, resistance lies at 25.91. The next price resistance is at 26.29. RSI (Relative Strength Index) is 42.37 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.30, which suggests the price will decrease in the coming days. Percent R is at 62.92%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
